Risk score to predict inpatient mortality of acute pancreatitis patients admitted to the intensive care unit.

IF 2.8 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pancreatology Pub Date : 2024-10-22 DOI:10.1016/j.pan.2024.10.010
Hassam Ali, Vishali Moond, Fnu Vikash, Dushyant Singh Dahiya, Manesh Kumar Gangwani, Amir Humza Sohail, Amy Chang, Jinye Liu, Umar Hayat, Pratik Patel, Mohamed Khalaf, Douglas G Adler
{"title":"Risk score to predict inpatient mortality of acute pancreatitis patients admitted to the intensive care unit.","authors":"Hassam Ali, Vishali Moond, Fnu Vikash, Dushyant Singh Dahiya, Manesh Kumar Gangwani, Amir Humza Sohail, Amy Chang, Jinye Liu, Umar Hayat, Pratik Patel, Mohamed Khalaf, Douglas G Adler","doi":"10.1016/j.pan.2024.10.010","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/objectives: </strong>Predicting inpatient mortality for acute pancreatitis (AP) patients in the ICU is crucial for optimal treatment planning. This study aims to develop a concise risk score model for this purpose, enhancing the predictability and management of AP in ICU settings.</p><p><strong>Methods: </strong>We included 380 patients in our training set. Twenty-seven variables were retrospectively collected, and predictive variables were selected using LASSO penalized regression and refined through backward elimination multivariate models. Effect sizes were used to create the final model to predict 7 and 30-day mortality among AP patients admitted to the ICU.</p><p><strong>Results: </strong>Of 380 patients, the mortality rate was 23.2 %. The final model included five predictors: INR, Albumin, Lactic Acid, BUN, and Bilirubin. The 5-fold cross-validated mean AUC was 0.93 (SD: 0.048) for 7-day mortality and 0.84 (SD: 0.033) for 30-day mortality, with a sensitivity of 77 % and specificity of 74 %. The risk score outperformed BISAP (AUC: 0.60) and APACHE-II (AUC: 0.76) in predicting mortality.</p><p><strong>Conclusion: </strong>Our model offers a convenient tool using commonly available laboratory results to predict mortality among AP patients, with potential applicability in both ICU settings.</p>","PeriodicalId":19976,"journal":{"name":"Pancreatology","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pancreatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.pan.2024.10.010","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background/objectives: Predicting inpatient mortality for acute pancreatitis (AP) patients in the ICU is crucial for optimal treatment planning. This study aims to develop a concise risk score model for this purpose, enhancing the predictability and management of AP in ICU settings.

Methods: We included 380 patients in our training set. Twenty-seven variables were retrospectively collected, and predictive variables were selected using LASSO penalized regression and refined through backward elimination multivariate models. Effect sizes were used to create the final model to predict 7 and 30-day mortality among AP patients admitted to the ICU.

Results: Of 380 patients, the mortality rate was 23.2 %. The final model included five predictors: INR, Albumin, Lactic Acid, BUN, and Bilirubin. The 5-fold cross-validated mean AUC was 0.93 (SD: 0.048) for 7-day mortality and 0.84 (SD: 0.033) for 30-day mortality, with a sensitivity of 77 % and specificity of 74 %. The risk score outperformed BISAP (AUC: 0.60) and APACHE-II (AUC: 0.76) in predicting mortality.

Conclusion: Our model offers a convenient tool using commonly available laboratory results to predict mortality among AP patients, with potential applicability in both ICU settings.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
预测入住重症监护室的急性胰腺炎患者住院死亡率的风险评分。
背景/目的:预测重症监护室急性胰腺炎(AP)患者的住院死亡率对于制定最佳治疗方案至关重要。本研究旨在为此开发一个简明的风险评分模型,以提高重症监护室中急性胰腺炎的可预测性和管理水平:方法:我们将 380 名患者纳入训练集。我们回顾性地收集了 27 个变量,使用 LASSO 惩罚回归法选出了预测变量,并通过反向消除多变量模型进行了改进。利用效应大小建立最终模型,预测入住重症监护室的 AP 患者 7 天和 30 天的死亡率:在 380 名患者中,死亡率为 23.2%。最终模型包括五个预测因子:INR、白蛋白、乳酸、尿素氮和胆红素。经 5 倍交叉验证,7 天死亡率的平均 AUC 为 0.93(标度:0.048),30 天死亡率的平均 AUC 为 0.84(标度:0.033),灵敏度为 77%,特异度为 74%。在预测死亡率方面,风险评分优于 BISAP(AUC:0.60)和 APACHE-II(AUC:0.76):我们的模型提供了一种方便的工具,利用常见的实验室结果预测 AP 患者的死亡率,可能适用于两种 ICU 环境。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pancreatology
Pancreatology 医学-胃肠肝病学
CiteScore
7.20
自引率
5.60%
发文量
194
审稿时长
44 days
期刊介绍: Pancreatology is the official journal of the International Association of Pancreatology (IAP), the European Pancreatic Club (EPC) and several national societies and study groups around the world. Dedicated to the understanding and treatment of exocrine as well as endocrine pancreatic disease, this multidisciplinary periodical publishes original basic, translational and clinical pancreatic research from a range of fields including gastroenterology, oncology, surgery, pharmacology, cellular and molecular biology as well as endocrinology, immunology and epidemiology. Readers can expect to gain new insights into pancreatic physiology and into the pathogenesis, diagnosis, therapeutic approaches and prognosis of pancreatic diseases. The journal features original articles, case reports, consensus guidelines and topical, cutting edge reviews, thus representing a source of valuable, novel information for clinical and basic researchers alike.
期刊最新文献
Imbalance in the vWF - ADAMTS13 axis exists early in acute pancreatitis and predicts persistent organ failure and pancreatic necrosis-a prospective study. Letter to the Editor regarding 'The duodenum-preserving head resection for chronic pancreatitis of Hans Günter Beger and subsequent modifications'. Letter to the Editor regarding 'EUS guided cyst Ablation of intraductal papillary mucinous neoplasm of the pancreas'. Relationships between postoperative recurrences and standardized uptake value on 18F-fluorodeoxyglucose-positron emission tomography in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma who underwent curative pancreatic resection after neoadjuvant chemoradiotherapy. Molecular aspects of BRAF and HER2 in prognosis of periampullary carcinoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1